BRPI0414069A - método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinámica antimicrobiana - Google Patents

método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinámica antimicrobiana

Info

Publication number
BRPI0414069A
BRPI0414069A BRPI0414069-9A BRPI0414069A BRPI0414069A BR PI0414069 A BRPI0414069 A BR PI0414069A BR PI0414069 A BRPI0414069 A BR PI0414069A BR PI0414069 A BRPI0414069 A BR PI0414069A
Authority
BR
Brazil
Prior art keywords
treatment area
bacteria
therapeutic composition
patient
safranin
Prior art date
Application number
BRPI0414069-9A
Other languages
English (en)
Inventor
Volker Albrecht
Burkhard Gitter
Original Assignee
Ceramoptec Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceramoptec Ind Inc filed Critical Ceramoptec Ind Inc
Publication of BRPI0414069A publication Critical patent/BRPI0414069A/pt
Publication of BRPI0414069A8 publication Critical patent/BRPI0414069A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO DE DESTRUIçãO DE BACTéRIAS EM áREA DE TRATAMENTO DO PACIENTE E RESPECTIVA COMPOSIçãO TERAPêUTICA FOTODINáMICA ANTIMICROBIANA". é revelado um método e composição para destruição de micróbios, especialmente bactérias, no corpo, utilizando Safranina O em conjunção com radiação eletromagnética. Num método preferido, uma composição compreendendo Safranina O é introduzida numa área de tratamento. Após ter passado um período de tempo suficiente, é aplicada radiação de um comprimento de onda adequado na área para ativar a Safranina O e, por uma reação fotodinâmica, destruir as bactérias. A radiação preferida tem um comprimento de onda em torno de 530 nm. Este método é efetivo para a destruição tanto de bactérias Gram-positivas como de Gram-negativas e é particularmente efetivo em áreas onde estão presentes meios complexos, tais como soro sangüíneo, sangue ou saliva.
BRPI0414069A 2003-09-02 2004-08-30 Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana BRPI0414069A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49984703P 2003-09-02 2003-09-02
US10/860,296 US20050049228A1 (en) 2003-09-02 2004-06-03 Antimicrobial photodynamic therapy compound and method of use
PCT/US2004/028180 WO2005021094A2 (en) 2003-09-02 2004-08-30 Antimicrobial photodynamic therapy compound

Publications (2)

Publication Number Publication Date
BRPI0414069A true BRPI0414069A (pt) 2006-10-24
BRPI0414069A8 BRPI0414069A8 (pt) 2016-10-11

Family

ID=34221799

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414069A BRPI0414069A8 (pt) 2003-09-02 2004-08-30 Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana

Country Status (6)

Country Link
US (1) US20050049228A1 (pt)
EP (1) EP1701726B1 (pt)
JP (1) JP4828423B2 (pt)
BR (1) BRPI0414069A8 (pt)
RU (1) RU2376991C2 (pt)
WO (1) WO2005021094A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
PT1951184E (pt) 2005-11-09 2012-04-10 Klox Technologies Inc Composições e métodos para branqueamento de dentes
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
WO2009075692A2 (en) 2007-05-14 2009-06-18 Invista Technologies S.A.R.L. High efficiency reactor and process
KR101835047B1 (ko) 2008-11-07 2018-03-08 클록스 테크놀로지스 인크. 히알루론산, 글루코사민 또는 알란토인을 포함하는 산화성의 광활성화된 피부 회춘용 조성물
US20120101427A1 (en) * 2009-04-28 2012-04-26 Gerard Farmer Novel photosensitizer formulations for oral administration
CN102802694B (zh) * 2009-06-02 2017-02-08 拜欧利泰克投资二代公司 使用抗微生物光动力疗法除去人类血液和血液制品中的微生物的新方法
CA2767889C (en) 2009-07-17 2017-01-03 Klox Technologies Inc. Antibacterial oral composition
BR112012017753A2 (pt) * 2010-01-19 2018-07-31 Biolitec Pharma Marketing Ltd. dispositivo e método de terapia fotodinâmica e usos de fotosensibilizadores.
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
BR112015005593B1 (pt) 2012-09-14 2019-09-24 Valeant Pharmaceuticals International, Inc. Método para branqueamento de dentes
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
CN106413766A (zh) 2014-04-01 2017-02-15 克洛克斯科技公司 组织填料组合物及使用方法
US11272594B2 (en) 2016-10-31 2022-03-08 Hubbell Incorporated Multi-array lighting system for providing high intensity narrow spectrum light
US10232066B2 (en) 2016-10-31 2019-03-19 Hubbell Incorporated High intensity narrow spectrum light indicator systems
US10702617B2 (en) 2017-10-30 2020-07-07 Hubbell Incorporated Antimicrobial backlit device
US11590248B2 (en) 2017-10-30 2023-02-28 Hubbell Lighting, Inc. Pulsing high intensity narrow spectrum light
RU2700407C1 (ru) * 2018-07-23 2019-09-16 Михаил Тимофеевич Александров Способ лечения опухолевых и воспалительных заболеваний с применением фотодинамической терапии
US11388789B2 (en) 2019-03-18 2022-07-12 Hubbell Lighting, Inc. Method for controlling operation of a lighting system having high intensity narrow spectrum light sources
US20220096634A1 (en) * 2020-09-30 2022-03-31 David A. Jernigan Method of manipulating phages within the body to attack infectious target cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798112A (en) * 1994-12-09 1998-08-25 The United States Of America As Represented By The Secretary Of Agriculture Phototoxic insecticidal composition and method for controlling insect populations
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
US5990199A (en) * 1995-04-19 1999-11-23 North American Science Associates, Inc. Indicator ink compositions
US6084005A (en) * 1997-02-24 2000-07-04 Kuraray Co., Ltd. Antimicrobial caries-detecting composition
US8187278B2 (en) * 1998-08-25 2012-05-29 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and benzalkonium chloride
US6506791B2 (en) * 2000-08-09 2003-01-14 Jacksonville State University Method of treatment of protozoan infections in fish
US6887862B2 (en) * 2001-05-31 2005-05-03 Miravant Systems, Inc. Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
EP1401479B1 (en) * 2001-06-04 2007-04-18 The General Hospital Corporation Detection and therapy of vulnerable plaque with photodynamic compounds
US6558653B2 (en) * 2001-09-19 2003-05-06 Scot N. Andersen Methods for treating periodontal disease
EP1670540A2 (en) * 2003-09-05 2006-06-21 The General Hospital Corporation Photodynamic inactivation of bacterial spores

Also Published As

Publication number Publication date
JP2007503917A (ja) 2007-03-01
RU2006110554A (ru) 2006-08-10
EP1701726A4 (en) 2007-01-03
BRPI0414069A8 (pt) 2016-10-11
EP1701726B1 (en) 2019-01-23
JP4828423B2 (ja) 2011-11-30
WO2005021094A2 (en) 2005-03-10
US20050049228A1 (en) 2005-03-03
RU2376991C2 (ru) 2009-12-27
WO2005021094A3 (en) 2005-04-28
EP1701726A2 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
BRPI0414069A (pt) método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinámica antimicrobiana
BRPI0414331A (pt) método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica
Usumez et al. Effects of laser irradiation at different wavelengths (660, 810, 980, and 1,064 nm) on mucositis in an animal model of wound healing
Vassena et al. Photodynamic antibacterial and antibiofilm activity of RLP068/Cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic material
Kato et al. Bactericidal efficacy of carbon dioxide laser against bacteria‐contaminated titanium implant and subsequent cellular adhesion to irradiated area
Caccianiga et al. Clinical, radiographic and microbiological evaluation of high level laser therapy, a new photodynamic therapy protocol, in peri‐implantitis treatment; a pilot experience
TR199802251T2 (xx) Herpes Simpleks vir�s� ve di�er enfeksiyonlu hastal�klar i�in antimikrobik tedavi i�in bile�imler.
CN1646191A (zh) 皮肤和指甲感染的防止和处理方法
Ribeiro et al. Photodynamic inactivation of microorganisms present on complete dentures. A clinical investigation: Photodynamic disinfection of complete dentures
BR0315088A (pt) Métodos para produção de um efeito antiangiogênico e/ou redutor de permeabilidade vascular em um animal de sangue quente e para tratamento de câncer em um animal de sangue quente, composição farmacêutica, kit, e, uso de zd6474 ou de um sal fermaceuticamento aceitável do mesmo e gencitabina
Bahrami et al. Anti-biofilm and bystander effects of antimicrobial photo-sonodynamic therapy against polymicrobial periopathogenic biofilms formed on coated orthodontic mini-screws with zinc oxide nanoparticles
Kamran et al. Impact of riboflavin mediated photodynamic disinfection around fixed orthodontic system infected with oral bacteria
BR0308285A (pt) Ruptura de biofilmes bacterianos por meio de enzimas
SG45225A1 (en) A novel physiologically active substance
AU5029599A (en) Methods for eradication of nanobacteria
BR0313117A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como um humano, composição farmacêutica, kit, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável e de zd1839 ou de um seu sal farmaceuticamente aceitável
Theodoro et al. Effect of antimicrobial photodynamic therapy on periodontally infected tooth sockets in rats
Roncati et al. Evaluation of light-emitting diode (led-835 nm) application over human gingival fibroblast: An in vitro study
Huang et al. Enhancing osteoblast functions on biofilm-contaminated titanium alloy by concentration-dependent use of methylene blue-mediated antimicrobial photodynamic therapy
Li et al. Extracorporeal shock wave therapy: A potential adjuvant treatment for peri-implantitis
Shukla et al. Association and contribution of dentistry in creating and sharing the burden of antibiotic-resistant microbial world
CN118973622A (zh) 紫外线照射装置及紫外线照射方法
Sommer Antiinfectives and low-level light: a new chapter in photomedicine
Wainwright Maggot therapy—a backwater in the fight against bacterial infection
Shukla et al. of Dentistry in Creating and Sharing

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BIOLITEC PHARMA MARKETING LTD. (MY)

B25A Requested transfer of rights approved

Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG (AT)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time